Efficacy and safety of Tafolecimab in Chinese patients with type 2 diabetes and hypercholesterolemia: a post-hoc analysis of pooled data from three phase 3 trials

Abstract Background This study evaluated the efficacy and safety of tafolecimab in patients with type 2 diabetes (T2D) and hypercholesterolemia by a post-hoc analysis of pooled data from three phase 3 trials. Methods Data from up to 12 weeks were analyzed to assess the effects of tafolecimab 450 mg...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Litong Qi, Hua Shen, Meng Chai, Beijian Chen, Yongming He, Xiaoxia Shi, Qiufang Lian, Wang Zhao, Yanling Qu, Lei Qian, Jianwei Zhang, Haoyu Li, Yujie Zhou, Yong Huo
Format:	Artigo
Język:	Inglês
Wydane:	BMC 2025-07-01
Seria:	Cardiovascular Diabetology
Hasła przedmiotowe:	Type 2 diabetes Hypercholesterolemia Low-density lipoprotein cholesterol Tafolecimab
Dostęp online:	https://doi.org/10.1186/s12933-025-02816-3
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!